Skip to content

LXRX - LEXICON PHARMACEUTICALS, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchL

Lexicon Pharmaceuticals Inc

LXRX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

L

LXRXLexicon Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $2.68
52-wk low: $1.03
Prev close: $1.95
Mkt cap: $1.07B
Beta: 1.03
P/S: 25.9x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$210.5M

P7
Point72
Steven Cohen · Q2 2026 13F
$19.8M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 5, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -147.4%
Market cap: $1.1B

Valuation

P/S25.86
P/B6.17

Quality

Operating margin-3835.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: LXRX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.07B
Beta: 1.03

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

6.2x

Profit margin

-147.4%

Op margin

-3835.0%

ROE

-40.2%

$3.8M

position

MW

Marshall Wace

Q1 2026 13F

$3.7M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for LXRX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.06+$0.00

-$0.06 expected

Next report

What the street expects next

-40.2%

ROA-14.3%

Growth

Beta1.03